XML 37 R25.htm IDEA: XBRL DOCUMENT v3.23.1
COMMON STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Tables)
12 Months Ended
Dec. 31, 2022
SCHEDULE OF SHARE OPTION ACTIVITY FOR EMPLOYEES AND MEMBERS

 

  

Number of

Share Options

  

Weighted

Average

Exercise Price

  

Weighted

average

remaining

contractual

life

  

Intrinsic

value

 
       $   (years)   $ 
                 
Outstanding as of December 31, 2020   128,297    64.46    5.42        - 
Granted   589,933    5.2    2.88    - 
Forfeited or expired   (98,177)   64.64    -    - 
Outstanding as of December 31, 2021   620,053    8.05    2.99    - 
Exercisable as of December 31, 2021   39,223    50.27    4.65    - 

 

  

Number of

Share Options

  

Weighted

Average

Exercise Price

  

Weighted

average

remaining

contractual

life

  

Intrinsic

value

 
       $   (years)   $ 
                 
Outstanding as of December 31, 2021   620,053    8.05    2.99    - 
Granted   115,857    5.2    2.68        - 
Forfeited or expired   -    -    -    - 
Outstanding as of December 31, 2022   735,910    7.6    2.1    - 
Exercisable as of December 31, 2022   245,535    12.4    2.58    - 
SCHEDULE OF OUTSTANDING AND EXERCISABLE SHARE OPTIONS

 

Exercise price - $ 

Share options

outstanding

as of

December 31,

2022

  

Weighted

average

remaining

contractual

term

  

Share options

exercisable

as of

December 31,

2022

  

Weighted

average

remaining

contractual

term

 
       (years)       (years) 
                 
100.75   3,846    4.26    3,846    4.26 
58.5   26,274    4.18    26,274    4.18 
5.2   705,790    2.01    215,415    1.91 
    735,910         245,535      
SCHEDULE OF ASSUMPTIONS USED TO VALUE OPTIONS

   2022   2021 
  

Year ended

December 31

 
   2022   2021 
         
Volatility (%)   72.15%   49.21%
Risk-free interest rate (%)   2.5%   2.5%
Dividend yield (%)   -    - 
Expected life (years)   3    3 
Exercise price ($)   5.2    5.2 
Share price ($)   1.89    3.1-4.65 
SCHEDULE OF TOTAL COMPENSATION COST EQUITY BASED AWARDS

 

Research and Development 

December 31,

2022

  

December 31,

2021

 
   In thousand of US dollars 
Research and Development 

December 31,

2022

  

December 31,

2021

 
         
Research and development   92    38 
General and administrative   395    223 
 Total compensation cost    487    261 
Non-Employee [Member]  
SCHEDULE OF OUTSTANDING AND EXERCISABLE SHARE OPTIONS

 

Exercise price - $ 

Share options

outstanding and

exercisable

December 31,

2022

  

Weighted average

remaining

contractual

term (years)

 
         
70.2   665,411    1.01 
46.8   665,411    1.01 
23.4   665,411    1.01 
6.5   13,398    0.63 
5.2   290,679    2.11 
3.35   4,068,497    1.56 
    6,368,807